Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Specimen Handling 149pembrolizumab 130Magnetic Resonance Spectroscopy 120Cyclophosphamide 117Biopsy 102fludarabine 89Nivolumab 58Carboplatin 53Cisplatin 48Radiotherapy 46Gemcitabine 46venetoclax 43Paclitaxel 41Cetuximab 41fludarabine phosphate 39Ipilimumab 35atezolizumab 34Fluorouracil 34Bevacizumab 33durvalumab 29Radiation 28Oxaliplatin 28Leucovorin 28Dexamethasone 28X-Rays 26Irinotecan 26Cytarabine 26Azacitidine 26Radiosurgery 24Injections 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × human papillomavirus vaccine, TA × 90 days × Clear all
NCT06315257 2026-05-20

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Recruiting
32 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡